We are live on ! Find out more
ALDR

Alder Biopharmaceuticals
ALDR

Delisted

ALDR was delisted on the 21st of October, 2019.

Back to rankings

139 hedge funds and large institutions have $1.11B invested in Alder Biopharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 38 increasing their positions, 49 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 17

24% more capital invested

Capital invested by funds: $893M → $1.11B (+$213M)

3% more funds holding

Funds holding: 135 → 139 (+4)

0% more funds holding in top 10

Funds holding in top 10: 5 → 5 (0)

22% less repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 49

87% less call options, than puts

Call options by funds: $1.88M | Put options by funds: $14.6M

Holders
139
Holders Change
+4
Holders Change %
+2.96%
% of All Funds
3.18%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
22
Increased
38
Reduced
49
Closed
17
Calls
$1.88M
Puts
$14.6M
Net Calls
-$12.8M
Net Calls Change
+$2.17M

Top Buyers

1
Citadel Advisors
Citadel Advisors
Florida
+$22.7M
2
SC
Samlyn Capital
New York
+$16.3M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$11.8M
4
LPC
Lion Point Capital
New York
+$8.84M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$6.5M

Top Sellers

1
State Street
State Street
Massachusetts
-$14.7M
2
SAM
Senzar Asset Management
New York
-$11.2M
3
Axa
Axa
France
-$8.18M
4
BlackRock
BlackRock
New York
-$6.98M
5
Ameriprise
Ameriprise
Minnesota
-$6.59M
Name Holding Trade Value Shares
Change 		Change in
Stake
Russell Investments Group
126
Russell Investments Group
United Kingdom
$38K +$36.5K +2,400 New
AG
127
Advisor Group
Arizona
$16K – – –
SEI Investments
128
SEI Investments
Pennsylvania
$16K – – –
CIBC Private Wealth Group
129
CIBC Private Wealth Group
Georgia
$16K +$15.2K +1,000 New
PIA
130
Piedmont Investment Advisors
North Carolina
$16K +$15.4K +1,012 New
RCM
131
Riverhead Capital Management
Delaware
$15K +$14.7K +965 New
Nisa Investment Advisors
132
Nisa Investment Advisors
Missouri
$11K +$5.77K +380 +119%
ME
133
McIlrath & Eck
Washington
$9K – – –
Daiwa Securities Group
134
Daiwa Securities Group
Japan
$6K – – –
LJHT
135
Laurie J. Hall Trustee
$6K – – –
Envestnet Asset Management
136
Envestnet Asset Management
Illinois
$4K – – –
NIT
137
NumerixS Investment Technologies
British Columbia, Canada
$2K -$263K -17,300 -99%
GRP
138
Global Retirement Partners
California
$1K – – –
PAMU
139
Pictet Asset Management (UK)
United Kingdom
– -$3.7M -291,120 Closed
TCM
140
Tekla Capital Management
Massachusetts
– -$3.56M -279,950 Closed
OA
141
Omega Advisors
New York
– -$2.41M -189,500 Closed
DZ Bank
142
DZ Bank
Germany
– -$1.59M -124,900 Closed
MCM
143
Moore Capital Management
New York
– -$1.27M -100,000 Closed
Balyasny Asset Management
144
Balyasny Asset Management
Illinois
– -$690K -54,349 Closed
SCA
145
Secor Capital Advisors
New York
– -$545K -42,942 Closed
MSL
146
Mackay Shields LLC
New York
– -$460K -36,220 Closed
BFM
147
Boothbay Fund Management
New York
– -$381K -30,000 Closed
Principal Financial Group
148
Principal Financial Group
Iowa
– -$155K -12,170 Closed
SKK
149
Shepherd Kaplan Krochuk
Massachusetts
– -$151K -11,900 Closed
EMG
150
Ellington Management Group
Connecticut
– -$142K -11,200 Closed
3 4 5
6
7

ALDR Hedge Fund Activity: Q2 2018 in Review

139 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Alder Biopharmaceuticals (ALDR) for Q2 2018, worth a combined $1.11B — up 24% from $893M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new ALDR positions and 17 closed out — a net gain of 5 holders — while 38 added to existing stakes and 49 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $22.7M. The largest seller was State Street, cutting an estimated $14.7M.

  • 139 institutional investors held Alder Biopharmaceuticals (ALDR) as of Q2 2018, up from 135 in Q1 2018.
  • Funds reported $1.11B of Alder Biopharmaceuticals stock for Q2 2018, up 24% quarter-over-quarter.
  • 22 funds opened new Alder Biopharmaceuticals positions in Q2 2018 and 17 closed out, a net change of +5 holders.
  • The largest Alder Biopharmaceuticals buyer in Q2 2018 was Citadel Advisors, an estimated $22.7M added.
  • The largest Alder Biopharmaceuticals seller in Q2 2018 was State Street, an estimated $14.7M sold.

Based on aggregated 13F filings for Q2 2018.